Tema Cardiovascular and Metabolic ETF
Not enough financial coverage to compute a composite score for HRTS. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companytemaetfs.com/hrts
The Tema Heart & Health ETF (HRTS) seeks to invest in companies that potentially stand to benefit from further advances in biotechnology and healthcare, specifically companies involved in cardiology, metabolic diseases and weight loss therapies.
- IPO
- 2023
- HQ
- New York, NY, US
Price Chart
Valuation
- Market Cap
- $49.94M
- Div Yield
- 1.41%
Performance & Tape
- 52W High
- $36.65
- 52W Low
- $26.79
- 50D MA
- $33.64
- 200D MA
- $33.39
- Beta
- 0.71
- Avg Volume
- 4.61K
Get TickerSpark's AI analysis on HRTS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HRTS Coverage
We haven't published any research on HRTS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HRTS Report →